Can the injected dose be reduced in 68Ga-PSMA-11 PET/CT maintaining high image quality for lesion detection?
Purpose: To define a clinically useful lower limit of injected dose for 68Ga-PSMA11 PET/CT imaging of prostate cancer. Methods: 68Ga-PSMA-11 PET/CT was performed in eleven patients. PET was acquired in list-mode and reconstructed using 3 min full acquisition, 2 min and 1 min to generate 3/3 (standard dose), 2/3 (low-dose) and 1/3 (very low-dose) of injected dose. Overall image quality (5-point scale) was assessed and detectability of PSMA-positive lesions was determined by three readers and compared to reference standard. Results: Image quality declined with decreasing dose (mean score standard dose: 4.1±0.4, low-dose: 3.4±0.7, very low-dose: 1.9±0.4; all p<0.05). Lesions (n = 21) were identified correctly in 100%, 100% and 95% on standard dose, in 95%, 81% and 90% on low-dose and in 71%, 76% and 59% on very low-dose images, by reader 1, 2 and 3, respectively. Conclusion: 68Ga-PSMA-11 dose reduction is not feasible without negative impact on image quality and lesion detectability.